Literature DB >> 21053062

Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses.

Guillermina A Melendi1, Dowd Bridget, Ana C Monsalvo, Federico F Laham, Patricio Acosta, Maria Florencia Delgado, Fernando P Polack, Pablo M Irusta.   

Abstract

The cytotoxic T-lymphocyte (CTL) response plays an important role in the control of respiratory syncytial virus (RSV) replication and the establishment of a Th1-CD4+ T cell response against the virus. Despite lacking Major Histocompatibility Complex I (MHC I)-restricted epitopes, the attachment G glycoprotein of RSV enhances CTL activity toward other RSV antigens, and this effect depends on its conserved central region. Here, we report that RSV-G can also improve CTL activity toward antigens from unrelated pathogens such as influenza, and that a mutant form of RSV-G lacking four conserved cysteine residues at positions 173, 176, 182, and 186 fails to enhance CTL responses. Our results indicate that these conserved residues are essential for the wide-spectrum pro-CTL activity displayed by the protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21053062      PMCID: PMC5454483          DOI: 10.1007/s11262-010-0545-9

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  42 in total

Review 1.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.

Authors:  Rui-hong Zeng; Wei Gong; Chang-fa Fan; Yun-fei Wang; Xing-guo Mei
Journal:  Vaccine       Date:  2005-08-30       Impact factor: 3.641

3.  CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.

Authors:  T Hussell; C J Baldwin; A O'Garra; P J Openshaw
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

4.  Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.

Authors:  J P Langedijk; B L de Groot; H J Berendsen; J T van Oirschot
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

5.  The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.

Authors:  Fernando P Polack; Pablo M Irusta; Scott J Hoffman; M Paula Schiatti; Guillermina A Melendi; M Florencia Delgado; Federico R Laham; Bhagvanji Thumar; R Michael Hendry; Jose A Melero; Ruth A Karron; Peter L Collins; Steven R Kleeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

6.  Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses.

Authors:  G T Belz; W Xie; P C Doherty
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses.

Authors:  Jennifer Harcourt; Rene Alvarez; Les P Jones; Christine Henderson; Larry J Anderson; Ralph A Tripp
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

8.  Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

Authors:  B S Graham; G S Henderson; Y W Tang; X Lu; K M Neuzil; D G Colley
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

9.  Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.

Authors:  M Connors; A B Kulkarni; P L Collins; C Y Firestone; K L Holmes; H C Morse; B R Murphy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains.

Authors:  Marietjie Venter; Michael Rock; Adrian J Puren; Caroline T Tiemessen; James E Crowe
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  11 in total

1.  Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Authors:  S Boyoglu-Barnum; S O Todd; J Meng; T R Barnum; T Chirkova; L M Haynes; S J Jadhao; R A Tripp; A G Oomens; M L Moore; L J Anderson
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

2.  Functional Analysis of the 60-Nucleotide Duplication in the Respiratory Syncytial Virus Buenos Aires Strain Attachment Glycoprotein.

Authors:  Anne L Hotard; Elizabeth Laikhter; Kelsie Brooks; Tina V Hartert; Martin L Moore
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

3.  Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.

Authors:  Seyhan Boyoglu-Barnum; Tatiana Chirkova; Sean O Todd; Thomas R Barnum; Kelsey A Gaston; Patricia Jorquera; Lia M Haynes; Ralph A Tripp; Martin L Moore; Larry J Anderson
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

4.  Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.

Authors:  Tatiana Chirkova; Seyhan Boyoglu-Barnum; Kelsey A Gaston; Fahad M Malik; Steven P Trau; Antonius G P Oomens; Larry J Anderson
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

5.  The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents.

Authors:  Thien N Nguyen; Ultan F Power; Alain Robert; Jean-François Haeuw; Katia Helffer; Amadeo Perez; Miguel-Angel Asin; Nathalie Corvaia; Christine Libon
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

Review 6.  Modulation of the host immune response by respiratory syncytial virus proteins.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 2.902

7.  Persistence and continuous evolution of the human respiratory syncytial virus in northern Taiwan for two decades.

Authors:  Hsin Chi; Kuang-Liang Hsiao; Li-Chuan Weng; Chang-Pan Liu; Hsin-Fu Liu
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

8.  Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.

Authors:  Patricia A Jorquera; Youngjoo Choi; Katie E Oakley; Thomas J Powell; James G Boyd; Naveen Palath; Lia M Haynes; Larry J Anderson; Ralph A Tripp
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

9.  The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection.

Authors:  Abhijeet A Bakre; Jennifer L Harcourt; Lia M Haynes; Larry J Anderson; Ralph A Tripp
Journal:  Vaccines (Basel)       Date:  2017-07-03

Review 10.  Functional Features of the Respiratory Syncytial Virus G Protein.

Authors:  Larry J Anderson; Samadhan J Jadhao; Clinton R Paden; Suxiang Tong
Journal:  Viruses       Date:  2021-07-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.